Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Prolonged systemic etretinate therapy and idiopathic skeletal hyperostosis.

    • 3 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Prolonged systemic etretinate therapy and idiopathic skeletal hyperostosis.. React. Wkly. 131, 3 (1985). https://doi.org/10.1007/BF03294531

    Download citation

    Keywords

    • Public Health
    • Clinical Efficacy
    • Half Life
    • Drug Accumulation
    • Biological Half Life